BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28992800)

  • 1. Antimalarial-induced cardiomyopathy: a systematic review of the literature.
    Tselios K; Deeb M; Gladman DD; Harvey P; Urowitz MB
    Lupus; 2018 Apr; 27(4):591-599. PubMed ID: 28992800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
    Tselios K; Deeb M; Gladman DD; Harvey P; Akhtari S; Mak S; Butany J; Urowitz MB
    J Rheumatol; 2019 Apr; 46(4):391-396. PubMed ID: 30323009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.
    Sabato LA; Mendes LA; Cox ZL
    J Pharm Pract; 2017 Oct; 30(5):571-575. PubMed ID: 27353145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine-induced cardiomyopathy-echocardiographic features.
    Naqvi TZ; Luthringer D; Marchevsky A; Saouf R; Gul K; Buchbinder NA
    J Am Soc Echocardiogr; 2005 Apr; 18(4):383-7. PubMed ID: 15846170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
    Godeau P; Guillevin L; Fechner J; Bletry O; Herreman G
    Ann Med Interne (Paris); 1981; 132(4):234-40. PubMed ID: 7305172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
    Tselios K; Gladman DD; Harvey P; Akhtari S; Su J; Urowitz MB
    J Rheumatol; 2019 Jan; 46(1):64-69. PubMed ID: 30068764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An atypical case of cardiomyopathy in a child: hypertrophic or restrictive cardiomyopathy?
    Maki T; Niimura I; Nishikawa T; Sekiguchi M
    Heart Vessels Suppl; 1990; 5():84-7. PubMed ID: 2093723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.
    Tselios K; Gladman DD; Harvey P; Su J; Urowitz MB
    Lupus; 2018 Aug; 27(9):1415-1423. PubMed ID: 29665757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyopathy related to antimalarial therapy with illustrative case report.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Delcourt A; Maisonobe T; Dorent R; Bonnet N; Sablé R; Lechat P; Wechsler B; Piette JC
    Cardiology; 2007; 107(2):73-80. PubMed ID: 16804295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction abnormalities in pediatric patients with restrictive cardiomyopathy.
    Walsh MA; Grenier MA; Jefferies JL; Towbin JA; Lorts A; Czosek RJ
    Circ Heart Fail; 2012 Mar; 5(2):267-73. PubMed ID: 22260945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.
    Seth S; Thatai D; Sharma S; Chopra P; Talwar KK
    Eur J Heart Fail; 2004 Oct; 6(6):723-9. PubMed ID: 15542407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic restrictive cardiomyopathy: clinical, hemodynamic, histologic and prognostic profile].
    Ortolani P; Rapezzi C; Binetti G; Baroni M; Mirri A; Alampi G; Benati A; Branzi A; Magnani B
    Cardiologia; 1989 Sep; 34(9):759-68. PubMed ID: 2605584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Doppler echocardiographic investigation of cardiomyopathies].
    Dubourg O; Bourdarias JP
    Arch Mal Coeur Vaiss; 1996 Jul; 89 Spec No 2():39-45. PubMed ID: 8881505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.
    Grupper A; Park SJ; Pereira NL; Schettle SD; Gerber Y; Topilsky Y; Edwards BS; Daly RC; Stulak JM; Joyce LD; Kushwaha SS
    J Heart Lung Transplant; 2015 Aug; 34(8):1042-9. PubMed ID: 25940074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restrictive cardiomyopathy.
    Zangwill S; Hamilton R
    Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S41-3. PubMed ID: 19602161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry.
    Webber SA; Lipshultz SE; Sleeper LA; Lu M; Wilkinson JD; Addonizio LJ; Canter CE; Colan SD; Everitt MD; Jefferies JL; Kantor PF; Lamour JM; Margossian R; Pahl E; Rusconi PG; Towbin JA;
    Circulation; 2012 Sep; 126(10):1237-44. PubMed ID: 22843787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restrictive cardiomyopathy].
    Langlard JM
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12 Suppl):59-64. PubMed ID: 9891823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.